Aridis Pharmaceuticals, Inc. Skyrocketed
Thu, Aug 31, 2023 at 07:07 PM
Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) rocketted at $0.11, representing a gain of 43.1%. On Thu, Aug 31, 2023, ARDS:NASDAQ hit a New 2-Week Intraday Low of $0.07. From Thu, Aug 17, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Jul 12, 2023 at $0.41 with a volume of 23M+.
About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 713.95%
- Aditxt Inc. (ADTX:NASDAQ), 461.22%
- Acer Therapeutics Inc. (ACER:NASDAQ), 109.84%
- Flora Growth Corp. (FLGC:NASDAQ), 77.31%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 60.76%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 43.08%
- SatixFy Communications Ltd. (SATX:NYSEMKT), 36.19%
- Vinco Ventures Inc. (BBIG:NASDAQ), 33.33%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 33.11%
- Leafly Holdings Inc. (LFLY:NASDAQ), 32.81%